Biologics

Research and Markets: U.S. Market for Orthopedic Biomaterials 2010

DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/9f7d82/u_s_market_for_or) has announced the addition of the “U.S. Market for Orthopedic Biomaterials 2010” report to their offering.

In 2009, the orthopedic biomaterials market was valued at almost $3.5 billion. This market is expected to grow at a CAGR of 8.9% by 2016. The total orthopedic biomaterials market has experienced growth, despite the economic downturn, which began in 2008. The market started to spike in 2009 and peaked in 2010 largely driven by rapid growth in the stem cell, hyaluronic acid and synthetic bone graft substitute market segments.

This comprehensive report critically examines the following market segments:

  • Bone graft substitutes
  • Cartilage repair
  • Growth factors
  • Hyaluronic acid
  • Machined allografts
  • Resorbable fixation
  • Stem cells
  • Tendon grafts
  • Platelet rich plasma
  • Bone marrow concentration systems

Within the U.S. orthopedic biomaterials market, companies such as Arthrex, DePuy, Genzyme, Medtronic, Synthes and Smith & Nephew lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2016, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

Keywords: bone graft substitutes, growth factors, machined allografts, hyaluronic acid viscosupplementation, resorbable fixation devices, tendon grafts, cartilage repair, platelet and bone marrow concentration, orthopedic stem cells and emerging technologies

Key Topics Covered:

EXECUTIVE SUMMARY 1.1 TOTAL ORTHOPEDIC BIOMATERIALS MARKET 1.2 GROWTH FACTOR AND BONE GRAFT SUBSTITUTE MARKET 1.3 MACHINED BONE ALLOGRAFT MARKET 1.4 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 1.5 RESORBABLE FIXATION DEVICE MARKET 1.6 TENDON GRAFT MARKET 1.7 CARTILAGE REPAIR MARKET 1.8 PLATELET AND BONE MARROW CONCENTRATION MARKET 1.9 STEM CELL MARKET 1.10 LEADING COMPETITORS

RESEARCH METHODOLOGY 2.1 RESEARCH SCOPE 2.2 IDATAS 9-STEP METHODOLOGY 2.2.1 Step 1: Project Initiation & Team Selection 2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research 2.2.3 Step 3: Preparation for Interviews & Questionnaire Design 2.2.4 Step 4: Performing Primary Research 2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates 2.2.6 Step 6: Market Forecast and Analysis 2.2.7 Step 7: Identify Strategic Opportunities 2.2.8 Step 8: Final Review and Market Release 2.2.9 Step 9: Customer Feedback and Market Monitoring

OVERVIEW OF ORTHOPEDIC BIOMATERIALS 3.1 INTRODUCTION 3.1.1 Growth Factors 3.1.2 Bone Graft Substitutes 3.1.3 Machined Bone Allografts 3.1.4 Hyaluronic Acid Viscosupplementation 3.1.5 Resorbable Fixation Devices 3.1.6 Tendon Grafts 3.1.7 Cartilage Repair 3.1.8 Platelet and Bone Marrow Concentration 3.1.9 Orthopedic Stem Cell Therapy 3.2 MARKET ANALYSIS AND FORECAST 3.3 MARKET DRIVERS AND LIMITERS 3.3.1 Market Drivers 3.3.2 Market Limiters 3.4 COMPETITIVE ANALYSIS 3.4.1 Market Concentration 3.5 MERGERS AND ACQUISITIONS

GROWTH FACTOR MARKET 4.1 INTRODUCTION 4.1.1 Overview 4.1.2 BMP-2 (Medtronic) 4.1.3 BMP-7 (Stryker) 4.1.4 Potential Complications 4.1.5 Reimbursement 4.1.6 Future Indications 4.2 MARKET ANALYSIS AND FORECAST 4.3 MARKET DRIVERS AND LIMITERS 4.3.1 Market Drivers 4.3.2 Market Limiters 4.4 COMPETITIVE ANALYSIS 4.4.1 Leading Competitors 4.4.2 Potential Competitors

BONE GRAFT SUBSTITUTE MARKET 5.1 INTRODUCTION 5.2 MARKET SEGMENTATION 5.2.1 Indications 5.2.2 Materials 5.3 MARKET ANALYSIS AND FORECAST 5.4 BONE GRAFT SUBSTITUTE MARKET BY INDICATION 5.4.1 Thoracolumbar Spinal Fixation Procedures 5.4.2 Thoracolumbar Spinal Bone Graft Substitute Market 5.4.3 Cervical Spinal Bone Graft Substitute Market 5.4.4 Trauma Bone Graft Substitute Market 5.4.5 Hip Bone Graft Substitute Market 5.4.6 Knee Bone Graft Substitute Market 5.4.7 Craniomaxillofacial Bone Graft Substitute Market 5.5 BONE GRAFT SUBSTITUTE MARKET BY MATERIAL 5.5.1 Autograft 5.5.2 Total Standard Allograft 5.5.3 Total DBM Market 5.5.4 Total Synthetic Bone Graft Substitute Market 5.6 MARKET DRIVERS AND LIMITERS 5.6.1 Market Drivers 5.6.2 Market Limiters 5.7 COMPETITIVE ANALYSIS 5.7.1 Total Bone Graft Substitute Market 5.7.2 Standard Allograft Market 5.7.3 DBM Market 5.7.4 Synthetic Bone Graft Substitute Market 5.7.5 Autograft Market

MACHINED BONE ALLOGRAFT MARKET 6.1 INTRODUCTION 6.1.1 Approaches 6.1.2 Interbody Device Procedure Percentages by Material 6.2 MARKET FORECAST AND ANALYSIS 6.2.1 ALIF Approach 6.2.2 PLIF Approach 6.2.3 TLIF Approach 6.2.4 Cervical Machined Bone Allografts 6.3 MARKET DRIVERS AND LIMITERS 6.3.1 Market Drivers 6.3.2 Market Limiters 6.4 COMPETITIVE ANALYSIS

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 7.1 INTRODUCTION 7.1.1 Benefits of Viscosupplementation 7.1.2 Synovial Fluid 7.1.3 Three-Injection Cycle Products 7.1.4 Five-Injection Cycle Products 7.1.5 Single-Injection Cycle Products 7.1.6 Reimbursement 7.2 MARKET ANALYSIS AND FORECAST 7.2.1 Three-Injection Cycle 7.2.2 Five-Injection Cycle Viscosupplementation Market 7.2.3 Single-Injection Cycle Viscosupplementation Market 7.3 MARKET DRIVERS AND LIMITERS 7.3.1 Market Drivers 7.3.2 Market Limiters 7.4 COMPETITIVE ANALYSIS

RESORBABLE FIXATION DEVICE MARKET 8.1 INTRODUCTION 8.1.1 Materials 8.1.2 Disadvantages Compared to Metal Fixation 8.1.3 Indications and Product Descriptions 8.2 MARKET ANALYSIS AND FORECAST 8.2.1 Total Resorbable Fixation Market 8.2.2 Shoulder Resorbable Fixation Market 8.2.3 Knee Resorbable Fixation Market 8.2.4 Meniscal Resorbable Fixation Market 8.3 MARKET DRIVERS AND LIMITERS 8.3.1 Market Drivers 8.3.2 Market Limiters 8.4 COMPETITIVE ANALYSIS 8.4.1 Leading Competitors 8.4.2 Other Notable Competitors

TENDON GRAFT MARKET 9.1 INTRODUCTION 9.1.1 ACL/PCL Reconstruction Procedures 9.1.2 Bone-Patellar Tendon-Bone (BTB) Graft, ACL/PCL Surgery 9.1.3 Allograft Tendons 9.1.4 Popularity of the Anterior Tibialis Autograft 9.1.5 Ligament and Tendon Synthetic Grafts 9.1.6 Ligament and Tendon Xenografts 9.2 MARKET FORECAST AND ANALYSIS 9.2.1 Total Tendon Graft Market 9.2.2 Analysis of Tendon Units Procured per Donor 9.3 MARKET DRIVERS AND LIMITERS 9.3.1 Market Drivers 9.3.2 Market Limiters 9.4 COMPETITIVE ANALYSIS

CARTILAGE REPAIR MARKET 10.1 INTRODUCTION 10.1.1 Methods for Cartilage Repair 10.2 MARKET ANALYSIS AND FORECAST 10.2.1 Cartilage Autograft Procedures 10.2.2 Total Cartilage Repair Market 10.2.3 Autologous Chondrocyte Implantation Market 10.2.4 Osteochondral Allograft Market 10.2.5 Meniscal Graft Market 10.3 MARKET DRIVERS AND LIMITERS 10.3.1 Market Drivers 10.3.2 Market Limiters 10.4 COMPETITIVE ANALYSIS 10.4.1 Leading Competitors 10.4.2 Emerging Competitors

PLATELET AND BONE MARROW CONCENTRATION MARKET 11.1 INTRODUCTION 11.1.1 Platelet Rich Plasma 11.1.2 Bone Marrow Aspirate 11.2 MARKET ANALYSIS AND FORECAST 11.2.1 Total Platelet and Bone Marrow Concentration Market 11.2.2 Spinal Platelet Concentration Market 11.2.3 Extremity and Sports Medicine Platelet Concentration Market 11.2.4 Bone Marrow Aspirate Concentration Market 11.3 MARKET DRIVERS AND LIMITERS 11.3.1 Market Drivers 11.3.2 Market Limiters 11.4 COMPETITIVE ANALYSIS 11.4.1 Leading Competitors 11.4.2 Other Competitors

ORTHOPEDIC STEM CELL MARKET 12.1 INTRODUCTION 12.2 MARKET OVERVIEW 12.2.1 Lineage 12.2.2 Legislation 12.2.3 Other Therapeutic Applications 12.3 MARKET ANALYSIS AND FORECAST 12.3.1 Lumbar Spine Stem Cell Market 12.3.2 Cervical Spine Stem Cell Market 12.4 MARKET DRIVERS AND LIMITERS 12.4.1 Market Drivers 12.4.2 Market Limiters 12.5 COMPETITIVE ANALYSIS 12.5.1 Leading Competitors 12.5.2 Potential Competitors

EMERGING TECHNOLOGIES 13.1 INTRODUCTION 13.1.1 Emerging Cartilage Repair Technologies 13.1.2 Emerging Bone Graft Substitute Technologies 13.1.3 Xenografts

Companies Mentioned:

  • Abbott Spine,
  • AlloSource
  • Alphatec Spine,
  • Altiva Corporation,
  • Anika
  • Arteriocyte
  • Arthrex
  • ArthroCare
  • Biomet
  • Bone Bank Allografts,
  • Clearant Inc.,
  • ConMed/Linvatec
  • DCI Donor Services,
  • DePuy
  • Donor Services,
  • + many more

For more information visit http://www.researchandmarkets.com/research/9f7d82/u_s_market_for_or

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button